It is essential when designing a controlled-release formulation to ensure robustness of API release. This is particularly important for APIs with a narrow therapeutic range.
In a discussion with PharmTech, our development scientist Brad Beissner joins other industry leaders to explore all things controlled release. He highlights how formulators and excipient providers can strengthen their manufacturing processes and determine the best formulations for better drug solubility.
Read the full article to find out how drug developers can overcome their solubility challenges and achieve their expected API release profiles.